IP Library Granted Patent US 7,605,145
Granted Patent B2
US 7,605,145 · App. 11/943,176 · Granted Oct 20, 2009

Micronutrient formulations for treatment of diabetes mellitus

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,605,145
App. No.
11/943,176
Granted
Oct 20, 2009
Kind
B2
Abstract

Formulations for minimizing damage to at least one of cells, organs and systems within the body of a subject afflicted with Diabetes Mellitus. The invention additionally encompasses methods for minimizing said damage which comprise administering to subjects in need thereof a therapeutic amount of a formulation(s) according to the invention.

Claims (74)

1. A formulation consisting of:

vitamin A (palmitate)

3,000-5000

I.U.

beta-carotene (from natural d. salina )

10-20

mg

vitamin D-3 (cholecalciferol)

200-600

I.U.

natural source vitamin E

(d-alpha tocopherol succinate)

100-400

I.U.

(d-alpha tocopheryl acetate)

100-400

I.U.

vitamin C (calcium ascorbate)

100-2000

mg

thiamine mononitrate

1-10

mg

riboflavin

1-20

mg

niacinamide ascorbate

10-60

mg

d-calcium pantothenate

5-30

mg

pyridoxine hydrochloride

1-10

mg

cyanocobalamin

5-30

mcg

folic acid (folacin)

400-1600

mcg

d-biotin

100-1600

mcg

selenium (I-seleno-methionine)

100-250

mcg

chromium picolinate

50-250

mcg

zinc glycinate

10-60

mg

calcium citrate

100-500

mg

magnesium citrate

50-250

mg

n-acetyl cysteine

100-500

mg

alpha lipoic acid

50-200

mg

co-enzyme Q10

10-200

mg

L-carnitine

100-400

mg

Said formulation is designed for the treatment of Diabetes Mellitus.

2. The formulation of claim 1 wherein said formulation is consumed by a user at least twice per day.

3. The formulation of claim 1 wherein said formulation is consumed is from about at least one week to about life long.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2022
From: JGB COLLATERAL, LLC
To: NABC, INC.
Reel/Frame 059383/0122 →
RELEASE OF SECURITY INTEREST Recorded Dec 22, 2020
From: EAST WEST BANK
To: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.; MORINDA, INC.
Reel/Frame 054733/0587 →
RELEASE OF SECURITY INTEREST Recorded Dec 7, 2020
From: EAST WEST BANK
To: NEWAGE, INC.; NABC, INC.; MORINDA, INC.
Reel/Frame 054560/0232 →
SECURITY INTEREST Recorded Dec 1, 2020
From: ARIEL MERGER SUB 2, LLC; NEWAGE, INC. (A WASHINGTON CORPORATION); NABC, INC.; MORINDA, INC.
To: JGB COLLATERAL, LLC (A DELAWARE LIMITED LIABILITY COMPANY)
Reel/Frame 054509/0837 →
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2019
From: DOMINION CAPITAL LLC
To: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.
Reel/Frame 048793/0288 →
SECURITY INTEREST Recorded Apr 1, 2019
From: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.; MORINDA, INC.
To: EAST WEST BANK
Reel/Frame 048752/0082 →
RELEASE OF SECURITY INTEREST Recorded Apr 1, 2019
From: SIENA LENDING GROUP LLC
To: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.
Reel/Frame 048752/0034 →
SECURITY INTEREST Recorded Aug 13, 2018
From: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES CORPORATION
To: SIENA LENDING GROUP LLC
Reel/Frame 046623/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2018
From: PREMIER MICRONUTRIENT CORPORATION
To: NEW AGE HEALTH SCIENCES, INC.
Reel/Frame 046599/0450 →
SECURITY INTEREST Recorded Jun 22, 2018
From: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.
To: DOMINION CAPITAL LLC
Reel/Frame 046181/0389 →
SECURITY AGREEMENT Recorded Dec 8, 2009
From: PREMIER MICRONUTRIENT CORPORATION
To: FIRSTBANK
Reel/Frame 023607/0868 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2007
From: PRASAD, KEDAR N.; COLE, WILLIAM C.; HAASE, GERALD M.
To: PREMIER MICRONUTRIENT CORPORATION
Reel/Frame 020188/0710 →